Innate and adaptive immunity in amyotrophic lateral sclerosis: Evidence of complement activation

Increasing evidence suggests a role for the immune system in amyotrophic lateral sclerosis (ALS). To determine the extent of the immune activation in ALS we analyzed the expression and cellular distribution of components of innate and adaptive immunity in spinal cord (SC) and motor cortex (MCx) from patients with rapid and slow sporadic ALS and controls. High levels of mRNA and protein of classical complement pathway, C1q and C4, as well as the downstream complement components C3 and C5b-9 were found in all ALS samples. Furthermore, we found higher numbers of activated microglia, reactive astrocytes, dendritic cells (DCs) and CD8+ T-cells in ALS than in control tissue. Rapid ALS cases had more dendritic cells than slow ALS cases, whereas slow ALS cases had more activated microglia than rapid cases.Our findings demonstrate a persistent and prominent activation of both innate and adaptive immunity in ALS. We propose a complement-driven immune response which may contribute to the progression of the inflammation and ultimately lead to even more motor neuron injury.

Abstract licence: CC BY-NC

• The good, the bad, and the opportunities of the complement system in neurodegenerative disease · 2020

• Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System · 2019

• Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington’s disease · 2019

• Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis · 2016

• Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis · 2014

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.